BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19558806)

  • 1. [Relationship between the efficacy of inhaled corticosteroids and the leukotriene expression in children with asthma].
    Wu JL; Chen AH; Peng QY; Chen RC; Zhong NS
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):441-4. PubMed ID: 19558806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
    Kopriva F; Dzubak P; Potesil J; Hajduch M
    J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary leukotrience E(4) level in children with asthma].
    He MJ; Chen Q; Liu JM
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):909-12. PubMed ID: 20113659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction.
    Rabinovitch N; Zhang L; Gelfand EW
    J Allergy Clin Immunol; 2006 Sep; 118(3):635-40. PubMed ID: 16950282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled corticosteroids do not affect behaviour.
    de Vries TW; van Roon EN; Duiverman EJ
    Acta Paediatr; 2008 Jun; 97(6):786-9. PubMed ID: 18397354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective observational study of clinical course after stopping inhaled corticosteroids in child asthma].
    Akasawa A; Suda T; Akashi M; Narita M; Ohya Y; Manki A; Watanabe H; Kumaki M; Matsumoto K; Saito H
    Arerugi; 2009 Oct; 58(10):1407-17. PubMed ID: 19901510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of inhaled corticosteroids on distribution of throat flora in children with bronchial asthma].
    Lin H; Sun Y; Lin RJ; Xu J; Li N
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 45(8):656-9. PubMed ID: 21055242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of the PTGDR and LTC4S influence responsiveness to leukotriene receptor antagonists in Korean children with asthma.
    Kang MJ; Kwon JW; Kim BJ; Yu J; Choi WA; Shin YJ; Hong SJ
    J Hum Genet; 2011 Apr; 56(4):284-9. PubMed ID: 21307858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene pathway polymorphisms are associated with altered cysteinyl leukotriene production in children with acute asthma.
    Bizzintino JA; Khoo SK; Zhang G; Martin AC; Rueter K; Geelhoed GC; Goldblatt J; Laing IA; Le Souëf PN; Hayden CM
    Prostaglandins Leukot Essent Fatty Acids; 2009 Jul; 81(1):9-15. PubMed ID: 19524426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inhaled steroid therapy on exhaled nitric oxide and bronchial responsiveness in children with asthma.
    Nishio K; Odajima H; Motomura C; Nakao F; Nishima S
    J Asthma; 2006 Dec; 43(10):739-43. PubMed ID: 17169825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
    Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
    Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids vs. leukotriene-receptor antagonists and asthma exacerbations in children.
    Blais L; Kettani FZ; Lemière C; Beauchesne MF; Perreault S; Elftouh N; Ducharme FM
    Respir Med; 2011 Jun; 105(6):846-55. PubMed ID: 21196105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing trends in asthma: a longitudinal observational study.
    Turner S; Thomas M; von Ziegenweidt J; Price D
    Arch Dis Child; 2009 Jan; 94(1):16-22. PubMed ID: 18701558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence that early use of inhaled corticosteroids reduces current asthma at 10 years of age.
    Devulapalli CS; Lødrup Carlsen KC; Håland G; Munthe-Kaas MC; Pettersen M; Mowinckel P; Carlsen KH
    Respir Med; 2007 Aug; 101(8):1625-32. PubMed ID: 17513101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.
    Higashi N; Taniguchi M; Mita H; Kawagishi Y; Ishii T; Higashi A; Osame M; Akiyama K
    J Allergy Clin Immunol; 2004 Feb; 113(2):277-83. PubMed ID: 14767442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma.
    Mastalerz L; Setkowicz M; Sanak M; Szczeklik A
    J Allergy Clin Immunol; 2004 Apr; 113(4):771-5. PubMed ID: 15100686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based pharmacologic treatment for mild asthma.
    Koh MS; Irving LB
    Int J Clin Pract; 2007 Aug; 61(8):1375-9. PubMed ID: 17590220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of asthma in preschool children with inhaled corticosteroids and leukotriene receptor antagonists.
    Bacharier LB
    Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):158-62. PubMed ID: 18317026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary leukotriene E4 and 9 alpha, 11 beta-prostaglandin F concentrations in mild, moderate and severe asthma, and in healthy subjects.
    Misso NL; Aggarwal S; Phelps S; Beard R; Thompson PJ
    Clin Exp Allergy; 2004 Apr; 34(4):624-31. PubMed ID: 15080817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.